Abstract |
Laryngeal cancer (LC) is an aggressive malignancy resistant to drug treatments. It has been postulated that cancer stem cells (CSCs) persist in a unique population of cancer cells involved in tumor progression and drug-resistance. In the present study, the effects of PLOD2 expression on ordinary and Cisplatin (DDP)-resistance (R) cells were investigated in TU686 and TU138 cells and Xenograft model. Cell viability, invasion and cell apoptosis, CD44 and CD133 expressions, MRP1 and P-gp expressions were measured by CCK-8 assay, Transwell, flow cytometry, immunofluorescence and Western blotting respectively. The results of our study demonstrated that suppressing the expression of PLOD2 could meditate LC stem cell-like features by decrease cell viability and invasion, increase apoptotic rate, decrease CD44 and CD133 expressions via Integrin β1. Meanwhile, the inhibition of PLOD2 expression could decrease P-gp and MRP1expression thus markedly regulate DDP-R LC cells stemness and drug-resistance via Integrin β1. Our findings provided a new rationale for subsequent academic and clinical research on LC drug-resistance.
|
Authors | Meiyan Song, Xing Liu, Tao Li, Yueqin Zhang, Xiaoyan Zhao, Wen Sun, Zhen Li |
Journal | Translational oncology
(Transl Oncol)
Vol. 22
Pg. 101460
(Aug 2022)
ISSN: 1936-5233 [Print] United States |
PMID | 35660870
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022. Published by Elsevier Inc. |